Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer's disease Ruchika Sharma27 July 2025 3:15 PM ISTBasel: Roche has announced it has received CE Mark for its Elecsys pTau181 test to measure phosphorylated Tau (pTau) 181 protein which is an...
Roche Itovebi gets European Commission nod in fight against advanced breast cancer Ruchika Sharma24 July 2025 2:30 PM ISTBasel: Roche has received approval from the European Commission for Itovebi (inavolisib), in combination with palbociclib (Ibrance) and...
Roche announces topline results from trials investigating astegolimab compared to placebo in COPD patients Ruchika Sharma21 July 2025 2:39 PM ISTBasel: Roche has announced topline results from the pivotal phase IIb ALIENTO (n=1,301) and the phase III ARNASA (n=1,375) trials investigating...
Roche announces retirement of senior executives Hans Clevers, Barbara Schadler Ruchika Sharma2 July 2025 11:00 AM ISTBasel: Roche has announced the upcoming retirement of two senior executives, Hans Clevers, Head of Pharma Research and Early Development (pRED),...
Roche to proceed with Phase III development of Prasinezumab in early-stage Parkinson's disease Ruchika Sharma17 Jun 2025 11:00 AM ISTBasel: Roche has announced its decision to proceed with Phase III development of prasinezumab, an investigational anti-alpha-synuclein antibody,...
Roche Evrysdi tablet gets European Commission approval for Spinal Muscular Atrophy Ruchika Sharma5 Jun 2025 2:00 PM ISTBasel: Roche has announced that the European Commission (EC) has approved a label extension for Evrysdi (risdiplam) to include a new,...
Roche Itovebi recommended by CHMP for EU approval for PIK3CA-mutated, ER-positive, HER2-negative, advanced breast cancer Ruchika Sharma25 May 2025 3:30 PM ISTBasel: Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive...
Roche Susvimo gets USFDA green light for Diabetic Retinopathy Ruchika Sharma23 May 2025 10:00 AM ISTBasel: Roche has received approval from the US Food and Drug Administration (FDA) for Susvimo (ranibizumab injection) 100 mg/mL for the treatment...
USFDA Advisory Committee reviews Roche Columvi Combo for diffuse large B-cell Lymphoma Ruchika Sharma21 May 2025 1:45 PM ISTBasel: Roche has announced that a US Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) discussed the supplemental...
Roche receives USFDA approval for VENTANA MET (SP44) RxDx Assay as companion diagnostic in non-small cell lung cancer Ruchika Sharma18 May 2025 2:30 PM ISTBasel: Roche has announced that the FDA has approved the VENTANA MET (SP44) RxDx Assay, the first companion diagnostic approved to aid in determining...
Zealand Pharma announces closing of collaboration, license agreement with Roche Ruchika Sharma11 May 2025 9:45 AM ISTDenmark: Zealand Pharma A/S, a biotechnology company focused on the discovery and development of peptide-based medicines, has announced that all...
Roche launches Elecsys PRO-C3 test for liver fibrosis Ruchika Sharma6 May 2025 11:30 AM ISTBasel: Roche has announced the launch of its ElecsysPRO-C3 test, a new diagnostic solution designed to assess the severity of liver fibrosis in...
